Press release
Worldwide Dysmenorrhea Treatment Market is Estimated to reach US$ 8.40 billion in 2023 and CAGR of approximately 12.28%
Pain during menstruation is known as dysmenorrhea. Increase in incidence of dysmenorrhea, which is attributed to changing lifestyle, addiction to smoking and alcohol, hormonal changes and physical and mental stress, favor the growth of this market. Additionally, lack of awareness regarding reproductive health and increase in first pregnancy age, favor the growth of this market.
Taste the market data and market information presented through more than 45 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Dysmenorrhea Treatment market Research Report –Global Forecast to 2023.”
Get a sample report at https://www.marketresearchfuture.com/sample_request/727 .
Global Dysmenorrhea Treatment Market Players:
Key players in Dysmenorrhea Treatment market are: Novartis AG (Switzerland), Merck, Inc. (U.S), Bayer Schering Pharma AG (Germany), Abbott Healthcare (U.S), Pfizer, Inc. (U.S). Other players include F. Hoffmann-La Roche Ltd (U.S), Sanofi (U.S), Taj Pharmaceuticals, Ltd (India).
Novartis AG is a multinational pharmaceutical company. It is one of the largest pharmaceutical companies in the world. The company excels in research & development activities in various branches of healthcare using science based innovations and new business approaches. CATAFLAM is a drug for treating primary dysmenorrhea.
Merck Inc. is a largest pharmaceutical company in the world. It manufactures medicines, vaccine and animal health products. The company produce products for key therapeutic areas like oncology, immunology, neuroscience, cardiovascular disease, respiratory disease, infectious disease, and women's health. “Cyclessa” is a drug manufactured by this company for prevention of pregnancy as a method of contraception.
Bayer Schering Pharma is a German chemical, pharmaceutical and Life Science Company. In June 2017, the company announced the launch of “Dan E Fu Kang ointment” for the treatment of menstrual disorders. It established a partnership with Dayima, a women health management platform in India.
Abbott Healthcare is a global healthcare and research company. Flurbiprofen is a non-steroidal anti-inflammatory agent prescribed for pain raising from dysmenorrhea.
Study Objectives:
Main objective of this research is to provide information about the products, their application and their end users
To provide detailed analysis of the market structure along with forecast for the next six years of the various segments and sub-segments of the Dysmenorrhea Treatment market.
To provide insights about factors affecting the market growth.
To analyze the dysmenorrhea treatment market based on various factors- Price Analysis, Supply Chain Analysis, Porters Five Force Analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific and Middle East and Africa.
To provide country level analysis of the market with respect to the current market size and future prospective.
To provide country level analysis of the market for segments by type, by treatment, by end users and its sub-segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Dysmenorrhea Treatment market.
Browse Complete Report at https://www.marketresearchfuture.com/reports/dysmenorrhea-treatment-market-727 .
Global dysmenorrhea treatment market has been segmented on the basis of type which includes primary dysmenorrhea and secondary dysmenorrhea. Secondary dysmenorrhea has sub-segments namely endometriosis, adenomyosis, uterine myomas, endometrial polyps, cervical stenosis, and obstructive malformations of genital tract. On the basis of treatment the market is segmented into non-steroidal anti-inflammatory drugs (NSAIDs), hormonal, and combined oral contraceptive. End users are hospitals and clinics, diagnostic centers, pharmaceutical companies and others.
Global Dysmenorrhea Treatment market has been segmented on the basis of Type which includes Primary Dysmenorrhea and Secondary Dysmenorrhea. Secondary Dysmenorrhea has sub-segments namely Endometriosis, Adenomyosis, Uterine myomas, Endometrial polyps, Cervical stenosis, Obstructive malformations of genital tract. On the basis of treatment the market is segmented into non-steroidal anti-inflammatory drugs (NSAIDs), hormonal, and combined oral contraceptive. End users are hospitals and clinics, diagnostic centers, pharmaceutical companies and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us
Market Research Future
Maharashtra, India
+1 646 845 9312
Email: sales@Marketresearchfuture.Com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Worldwide Dysmenorrhea Treatment Market is Estimated to reach US$ 8.40 billion in 2023 and CAGR of approximately 12.28% here
News-ID: 934330 • Views: …
More Releases from Market Research Future
Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
The Glue Machine Market is witnessing significant growth due to the increasing adoption of adhesive technologies across various industries, including packaging, woodworking, automotive, furniture, and construction. Valued at USD 9.15 billion in 2024, the market is projected to reach USD 14.9 billion by 2035, registering a CAGR of 4.56% between 2025 and 2035.
Glue machines, also known as adhesive application machines, are critical for efficiently dispensing adhesives in industrial and commercial…
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
The expansion valves market is witnessing steady growth due to increasing demand for efficient heating, ventilation, air conditioning, and refrigeration (HVACR) systems across residential, commercial, and industrial sectors. Valued at USD 3.28 billion in 2024, the market is projected to reach USD 5.39 billion by 2035, growing at a CAGR of 4.62% between 2025 and 2035.
Expansion valves, also known as thermostatic expansion valves (TXVs) or electronic expansion valves (EEVs), are…
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CA …
The Cheese Packaging Market is poised for steady growth over the next decade due to rising demand for dairy products, evolving consumer preferences, and increasing focus on food safety and sustainability. According to recent estimates, the market was valued at USD 71.87 billion in 2024 and is projected to reach USD 101.31 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.50% between 2025 and 2034.
Cheese packaging…
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
The Maritime Market is a cornerstone of international trade, logistics, and economic connectivity, serving as the backbone of global commerce. Valued at USD 2,181.1 billion in 2024, the market is projected to expand to USD 2,920 billion by 2035, registering a steady CAGR of 2.69% between 2025 and 2035. Despite modest growth, the industry's scale and importance are unmatched, as more than 80% of global trade volume is carried by…
More Releases for Dysmenorrhea
Dysmenorrhea Market Share, Epidemiology, Analysis & Trends 2023-2033
Market Overview:
The dysmenorrhea market is expected to exhibit a CAGR of 5.67% during 2023-2033. The dysmenorrhea market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven major…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Global Dysmenorrhea Market report from Global Insight Services is the single authoritative source of intelligence on Dysmenorrhea market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of menstru*tion and last for the first few days of…
Dysmenorrhea - Drug Pipeline Landscape, 2022
Dysmenorrhea, also known as painful periods or menstrual cramps, is a common problem experienced by women during their reproductive years. It is estimated that 50-90% of women of reproductive age suffer from dysmenorrhea. The pain is usually felt in the lower abdomen and can range from mild to severe. The pain may begin one to two days before the start of and last for the first few days of…
Dysmenorrhea Treatment Market: Market Intelligence and Market Trends
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
Dysmenorrhea Treatment Market size and forecast, 2016-2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause…
